TrialNeuro-oncology2010

Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study.

Alexandre Carpentier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.